Daniel Saure
Heidelberg, BW 69120, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Do You Want to Stay Single? Considerations on Single-Arm Trials in Drug Development and the Postregulatory Space.
Journal: Pharmaceutical statistics
Published: December 06, 2023
Validating the Assumptions of Population Adjustment: Application of Multilevel Network Meta-regression to a Network of Treatments for Plaque Psoriasis.
Journal: Medical decision making : an international journal of the Society for Medical Decision Making
Published: August 23, 2022
Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic review.
Journal: Skin health and disease
Published: December 15, 2021
Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 2.
Journal: Journal of clinical medicine
Published: May 10, 2021
Cardiac Rehabilitation in German Speaking Countries of Europe-Evidence-Based Guidelines from Germany, Austria and Switzerland LLKardReha-DACH-Part 1.
Journal: Journal of clinical medicine
Published: February 21, 2021
Dynamic Visual Representation of Clinical Efficacy of Ixekizumab in Psoriasis.
Journal: Dermatology and therapy
Published: February 12, 2021
Impact of clinical and demographic characteristics on patient preferences for psoriasis treatment features: Results from a discrete-choice experiment in a multicountry study.
Journal: The Journal of dermatological treatment
Published: January 07, 2021
Multilevel network meta-regression for population-adjusted treatment comparisons.
Journal: Journal of the Royal Statistical Society. Series A, (Statistics in Society)
Published: July 21, 2020
Efficacy and safety of ixekizumab after switching from fumaric acid esters or methotrexate in patients with moderate-to-severe plaque psoriasis naïve to systemic treatment.
Journal: The British journal of dermatology
Published: July 06, 2020
Ixekizumab and ustekinumab in psoriasis: post-hoc comparison of onset and duration of treatment response.
Journal: The Journal of dermatological treatment
Published: June 13, 2020
Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12.
Journal: The Journal of dermatological treatment
Published: April 18, 2020
Modeling Heterogeneity in Patients' Preferences for Psoriasis Treatments in a Multicountry Study: A Comparison Between Random-Parameters Logit and Latent Class Approaches.
Journal: PharmacoEconomics
Published: March 05, 2020
Last Updated: 09/26/2026